Cumberland Pharmaceuticals (CPIX) Misses Q3 EPS by 10c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, $0.10 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $10.4 million versus the consensus estimate of $12.65 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Freeport-McMoran (FCX) Tops Q1 EPS by 3c
• Preferred Bank (PFBC) Tops Q1 EPS by 6c